Research output per year
Research output per year
Search results
-
2024
New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe
Houda, I., Dickhoff, C., Uyl-de Groot, C. A., Reguart, N., Provencio, M., Levy, A., Dziadziuszko, R., Pompili, C., Di Maio, M., Thomas, M., Brunelli, A., Popat, S., Senan, S. & Bahce, I., Mar 2024, In: The Lancet Regional Health - Europe. 38, p. 100840 100840.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access3 Citations (Scopus) -
2022
Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy
van Duijvenvoorde, M., Derks, S., Bahce, I., Leemans, C. R., van de Ven, R. & Fransen, M. F., 2022, In: Clinical & translational immunology. 11, 1, p. e1363 e1363.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access2 Citations (Scopus) -
Current state and upcoming opportunities for immunoPET biomarkers in lung cancer
Slebe, M., Pouw, J. E. E., Hashemi, S. M. S., van Oordt, C. W. M. D. H., Yaqub, M. M. & Bahce, I., Jul 2022, In: Lung Cancer. 169, p. 84-93 10 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access1 Citation (Scopus) -
2021
Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review: a systematic review
Ulas, E. B., Dickhoff, C., Schneiders, F. L., Senan, S. & Bahce, I., 31 Aug 2021, In: ESMO open. 6, 5, 100244.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access39 Citations (Scopus)